IL‐17A, IL‐17F, IL‐17AF, and TNF‐α were added to RA or PsA synovial fibroblasts in the presence of IL‐17A, IL‐17F, or dual IL‐17A/IL‐17F blocking antibodies. Here, TNF is linked to rheumatoid arthritis.